nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—CYP3A4—Esomeprazole—Barrett's esophagus	0.263	0.389	CbGbCtD
Methylprednisolone—ABCB1—Omeprazole—Barrett's esophagus	0.259	0.382	CbGbCtD
Methylprednisolone—CYP3A4—Omeprazole—Barrett's esophagus	0.155	0.229	CbGbCtD
Methylprednisolone—Oesophageal candidiasis—Omeprazole—Barrett's esophagus	0.0179	0.0583	CcSEcCtD
Methylprednisolone—Oesophageal candidiasis—Esomeprazole—Barrett's esophagus	0.0179	0.0583	CcSEcCtD
Methylprednisolone—Multiple fractures—Esomeprazole—Barrett's esophagus	0.00564	0.0183	CcSEcCtD
Methylprednisolone—Fracture—Esomeprazole—Barrett's esophagus	0.00564	0.0183	CcSEcCtD
Methylprednisolone—Multiple fractures—Omeprazole—Barrett's esophagus	0.00564	0.0183	CcSEcCtD
Methylprednisolone—Fracture—Omeprazole—Barrett's esophagus	0.00564	0.0183	CcSEcCtD
Methylprednisolone—Optic neuritis—Omeprazole—Barrett's esophagus	0.00533	0.0173	CcSEcCtD
Methylprednisolone—Optic neuritis—Esomeprazole—Barrett's esophagus	0.00533	0.0173	CcSEcCtD
Methylprednisolone—Fungal infection—Omeprazole—Barrett's esophagus	0.00424	0.0138	CcSEcCtD
Methylprednisolone—Fungal infection—Esomeprazole—Barrett's esophagus	0.00424	0.0138	CcSEcCtD
Methylprednisolone—Necrosis—Omeprazole—Barrett's esophagus	0.00418	0.0136	CcSEcCtD
Methylprednisolone—Necrosis—Esomeprazole—Barrett's esophagus	0.00418	0.0136	CcSEcCtD
Methylprednisolone—Glycosuria—Esomeprazole—Barrett's esophagus	0.00405	0.0131	CcSEcCtD
Methylprednisolone—Glycosuria—Omeprazole—Barrett's esophagus	0.00405	0.0131	CcSEcCtD
Methylprednisolone—Petechiae—Esomeprazole—Barrett's esophagus	0.00398	0.0129	CcSEcCtD
Methylprednisolone—Petechiae—Omeprazole—Barrett's esophagus	0.00398	0.0129	CcSEcCtD
Methylprednisolone—Arthropathy—Esomeprazole—Barrett's esophagus	0.0036	0.0117	CcSEcCtD
Methylprednisolone—Arthropathy—Omeprazole—Barrett's esophagus	0.0036	0.0117	CcSEcCtD
Methylprednisolone—Leukocytosis—Omeprazole—Barrett's esophagus	0.00349	0.0113	CcSEcCtD
Methylprednisolone—Leukocytosis—Esomeprazole—Barrett's esophagus	0.00349	0.0113	CcSEcCtD
Methylprednisolone—Hiccups—Omeprazole—Barrett's esophagus	0.00328	0.0106	CcSEcCtD
Methylprednisolone—Hiccups—Esomeprazole—Barrett's esophagus	0.00328	0.0106	CcSEcCtD
Methylprednisolone—Fluid retention—Omeprazole—Barrett's esophagus	0.00311	0.0101	CcSEcCtD
Methylprednisolone—Fluid retention—Esomeprazole—Barrett's esophagus	0.00311	0.0101	CcSEcCtD
Methylprednisolone—Oesophagitis—Esomeprazole—Barrett's esophagus	0.00299	0.00972	CcSEcCtD
Methylprednisolone—Oesophagitis—Omeprazole—Barrett's esophagus	0.00299	0.00972	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00273	0.00888	CcSEcCtD
Methylprednisolone—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00273	0.00888	CcSEcCtD
Methylprednisolone—Injury—Omeprazole—Barrett's esophagus	0.00259	0.0084	CcSEcCtD
Methylprednisolone—Injury—Esomeprazole—Barrett's esophagus	0.00259	0.0084	CcSEcCtD
Methylprednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—FOXF1—Barrett's esophagus	0.00256	0.181	CbGpPWpGaD
Methylprednisolone—Increased appetite—Esomeprazole—Barrett's esophagus	0.00253	0.00822	CcSEcCtD
Methylprednisolone—Increased appetite—Omeprazole—Barrett's esophagus	0.00253	0.00822	CcSEcCtD
Methylprednisolone—Osteoarthritis—Esomeprazole—Barrett's esophagus	0.00238	0.00773	CcSEcCtD
Methylprednisolone—Osteoarthritis—Omeprazole—Barrett's esophagus	0.00238	0.00773	CcSEcCtD
Methylprednisolone—Irritability—Esomeprazole—Barrett's esophagus	0.00227	0.00737	CcSEcCtD
Methylprednisolone—Irritability—Omeprazole—Barrett's esophagus	0.00227	0.00737	CcSEcCtD
Methylprednisolone—Breast disorder—Omeprazole—Barrett's esophagus	0.00215	0.00698	CcSEcCtD
Methylprednisolone—Breast disorder—Esomeprazole—Barrett's esophagus	0.00215	0.00698	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.0021	0.00681	CcSEcCtD
Methylprednisolone—Muscular weakness—Esomeprazole—Barrett's esophagus	0.0021	0.00681	CcSEcCtD
Methylprednisolone—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.0021	0.00681	CcSEcCtD
Methylprednisolone—Muscular weakness—Omeprazole—Barrett's esophagus	0.0021	0.00681	CcSEcCtD
Methylprednisolone—Abdominal distension—Esomeprazole—Barrett's esophagus	0.00207	0.00672	CcSEcCtD
Methylprednisolone—Abdominal distension—Omeprazole—Barrett's esophagus	0.00207	0.00672	CcSEcCtD
Methylprednisolone—Bronchospasm—Omeprazole—Barrett's esophagus	0.00202	0.00657	CcSEcCtD
Methylprednisolone—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00202	0.00657	CcSEcCtD
Methylprednisolone—Pancreatitis—Omeprazole—Barrett's esophagus	0.00202	0.00655	CcSEcCtD
Methylprednisolone—Pancreatitis—Esomeprazole—Barrett's esophagus	0.00202	0.00655	CcSEcCtD
Methylprednisolone—Sweating increased—Omeprazole—Barrett's esophagus	0.002	0.0065	CcSEcCtD
Methylprednisolone—Sweating increased—Esomeprazole—Barrett's esophagus	0.002	0.0065	CcSEcCtD
Methylprednisolone—Weight increased—Omeprazole—Barrett's esophagus	0.00187	0.00608	CcSEcCtD
Methylprednisolone—Weight increased—Esomeprazole—Barrett's esophagus	0.00187	0.00608	CcSEcCtD
Methylprednisolone—Infestation NOS—Esomeprazole—Barrett's esophagus	0.00183	0.00595	CcSEcCtD
Methylprednisolone—Infestation—Esomeprazole—Barrett's esophagus	0.00183	0.00595	CcSEcCtD
Methylprednisolone—Infestation NOS—Omeprazole—Barrett's esophagus	0.00183	0.00595	CcSEcCtD
Methylprednisolone—Infestation—Omeprazole—Barrett's esophagus	0.00183	0.00595	CcSEcCtD
Methylprednisolone—Bradycardia—Omeprazole—Barrett's esophagus	0.00168	0.00544	CcSEcCtD
Methylprednisolone—Bradycardia—Esomeprazole—Barrett's esophagus	0.00168	0.00544	CcSEcCtD
Methylprednisolone—Rhinitis—Omeprazole—Barrett's esophagus	0.00165	0.00536	CcSEcCtD
Methylprednisolone—Rhinitis—Esomeprazole—Barrett's esophagus	0.00165	0.00536	CcSEcCtD
Methylprednisolone—Hallucination—Esomeprazole—Barrett's esophagus	0.00164	0.00532	CcSEcCtD
Methylprednisolone—Hallucination—Omeprazole—Barrett's esophagus	0.00164	0.00532	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.00162	0.00525	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.00162	0.00525	CcSEcCtD
Methylprednisolone—Visual impairment—Omeprazole—Barrett's esophagus	0.00159	0.00515	CcSEcCtD
Methylprednisolone—Visual impairment—Esomeprazole—Barrett's esophagus	0.00159	0.00515	CcSEcCtD
Methylprednisolone—Eye disorder—Esomeprazole—Barrett's esophagus	0.00154	0.00499	CcSEcCtD
Methylprednisolone—Eye disorder—Omeprazole—Barrett's esophagus	0.00154	0.00499	CcSEcCtD
Methylprednisolone—Immune system disorder—Esomeprazole—Barrett's esophagus	0.00149	0.00483	CcSEcCtD
Methylprednisolone—Immune system disorder—Omeprazole—Barrett's esophagus	0.00149	0.00483	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.00148	0.00482	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.00148	0.00482	CcSEcCtD
Methylprednisolone—Mental disorder—Esomeprazole—Barrett's esophagus	0.00144	0.00468	CcSEcCtD
Methylprednisolone—Mental disorder—Omeprazole—Barrett's esophagus	0.00144	0.00468	CcSEcCtD
Methylprednisolone—Malnutrition—Omeprazole—Barrett's esophagus	0.00143	0.00465	CcSEcCtD
Methylprednisolone—Malnutrition—Esomeprazole—Barrett's esophagus	0.00143	0.00465	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.00133	0.00432	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.00133	0.00432	CcSEcCtD
Methylprednisolone—Angioedema—Esomeprazole—Barrett's esophagus	0.00131	0.00425	CcSEcCtD
Methylprednisolone—Angioedema—Omeprazole—Barrett's esophagus	0.00131	0.00425	CcSEcCtD
Methylprednisolone—Malaise—Omeprazole—Barrett's esophagus	0.00129	0.0042	CcSEcCtD
Methylprednisolone—Malaise—Esomeprazole—Barrett's esophagus	0.00129	0.0042	CcSEcCtD
Methylprednisolone—Vertigo—Esomeprazole—Barrett's esophagus	0.00129	0.00418	CcSEcCtD
Methylprednisolone—Vertigo—Omeprazole—Barrett's esophagus	0.00129	0.00418	CcSEcCtD
Methylprednisolone—Hypertension—Esomeprazole—Barrett's esophagus	0.00124	0.00402	CcSEcCtD
Methylprednisolone—Hypertension—Omeprazole—Barrett's esophagus	0.00124	0.00402	CcSEcCtD
Methylprednisolone—Arthralgia—Esomeprazole—Barrett's esophagus	0.00122	0.00396	CcSEcCtD
Methylprednisolone—Arthralgia—Omeprazole—Barrett's esophagus	0.00122	0.00396	CcSEcCtD
Methylprednisolone—Myalgia—Esomeprazole—Barrett's esophagus	0.00122	0.00396	CcSEcCtD
Methylprednisolone—Myalgia—Omeprazole—Barrett's esophagus	0.00122	0.00396	CcSEcCtD
Methylprednisolone—Anxiety—Esomeprazole—Barrett's esophagus	0.00122	0.00395	CcSEcCtD
Methylprednisolone—Anxiety—Omeprazole—Barrett's esophagus	0.00122	0.00395	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.00121	0.00393	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.00121	0.00393	CcSEcCtD
Methylprednisolone—Discomfort—Omeprazole—Barrett's esophagus	0.00121	0.00391	CcSEcCtD
Methylprednisolone—Discomfort—Esomeprazole—Barrett's esophagus	0.00121	0.00391	CcSEcCtD
Methylprednisolone—Confusional state—Esomeprazole—Barrett's esophagus	0.00118	0.00383	CcSEcCtD
Methylprednisolone—Confusional state—Omeprazole—Barrett's esophagus	0.00118	0.00383	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.00117	0.0038	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.00117	0.0038	CcSEcCtD
Methylprednisolone—Infection—Omeprazole—Barrett's esophagus	0.00116	0.00377	CcSEcCtD
Methylprednisolone—Infection—Esomeprazole—Barrett's esophagus	0.00116	0.00377	CcSEcCtD
Methylprednisolone—Shock—Esomeprazole—Barrett's esophagus	0.00115	0.00374	CcSEcCtD
Methylprednisolone—Shock—Omeprazole—Barrett's esophagus	0.00115	0.00374	CcSEcCtD
Methylprednisolone—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00115	0.00372	CcSEcCtD
Methylprednisolone—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00115	0.00372	CcSEcCtD
Methylprednisolone—Tachycardia—Esomeprazole—Barrett's esophagus	0.00114	0.00371	CcSEcCtD
Methylprednisolone—Tachycardia—Omeprazole—Barrett's esophagus	0.00114	0.00371	CcSEcCtD
Methylprednisolone—Skin disorder—Esomeprazole—Barrett's esophagus	0.00114	0.00369	CcSEcCtD
Methylprednisolone—Skin disorder—Omeprazole—Barrett's esophagus	0.00114	0.00369	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.00113	0.00367	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.00113	0.00367	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.00107	0.00346	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.00107	0.00346	CcSEcCtD
Methylprednisolone—Insomnia—Omeprazole—Barrett's esophagus	0.00106	0.00343	CcSEcCtD
Methylprednisolone—Insomnia—Esomeprazole—Barrett's esophagus	0.00106	0.00343	CcSEcCtD
Methylprednisolone—Paraesthesia—Omeprazole—Barrett's esophagus	0.00105	0.00341	CcSEcCtD
Methylprednisolone—Paraesthesia—Esomeprazole—Barrett's esophagus	0.00105	0.00341	CcSEcCtD
Methylprednisolone—Dyspepsia—Omeprazole—Barrett's esophagus	0.00103	0.00334	CcSEcCtD
Methylprednisolone—Dyspepsia—Esomeprazole—Barrett's esophagus	0.00103	0.00334	CcSEcCtD
Methylprednisolone—Fatigue—Esomeprazole—Barrett's esophagus	0.00101	0.00327	CcSEcCtD
Methylprednisolone—Fatigue—Omeprazole—Barrett's esophagus	0.00101	0.00327	CcSEcCtD
Methylprednisolone—ABCB1—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000997	0.0704	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptors—NR1I2—Barrett's esophagus	0.000976	0.0688	CbGpPWpGaD
Methylprednisolone—Feeling abnormal—Omeprazole—Barrett's esophagus	0.000963	0.00313	CcSEcCtD
Methylprednisolone—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.000963	0.00313	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000956	0.0031	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000956	0.0031	CcSEcCtD
Methylprednisolone—Urticaria—Omeprazole—Barrett's esophagus	0.000929	0.00302	CcSEcCtD
Methylprednisolone—Urticaria—Esomeprazole—Barrett's esophagus	0.000929	0.00302	CcSEcCtD
Methylprednisolone—Abdominal pain—Omeprazole—Barrett's esophagus	0.000924	0.003	CcSEcCtD
Methylprednisolone—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000924	0.003	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CRTC1—Barrett's esophagus	0.000863	0.0609	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000861	0.0028	CcSEcCtD
Methylprednisolone—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000861	0.0028	CcSEcCtD
Methylprednisolone—Asthenia—Omeprazole—Barrett's esophagus	0.000839	0.00272	CcSEcCtD
Methylprednisolone—Asthenia—Esomeprazole—Barrett's esophagus	0.000839	0.00272	CcSEcCtD
Methylprednisolone—Pruritus—Esomeprazole—Barrett's esophagus	0.000827	0.00269	CcSEcCtD
Methylprednisolone—Pruritus—Omeprazole—Barrett's esophagus	0.000827	0.00269	CcSEcCtD
Methylprednisolone—Diarrhoea—Omeprazole—Barrett's esophagus	0.0008	0.0026	CcSEcCtD
Methylprednisolone—Diarrhoea—Esomeprazole—Barrett's esophagus	0.0008	0.0026	CcSEcCtD
Methylprednisolone—Dizziness—Esomeprazole—Barrett's esophagus	0.000773	0.00251	CcSEcCtD
Methylprednisolone—Dizziness—Omeprazole—Barrett's esophagus	0.000773	0.00251	CcSEcCtD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—NR1I2—Barrett's esophagus	0.000771	0.0544	CbGpPWpGaD
Methylprednisolone—Vomiting—Omeprazole—Barrett's esophagus	0.000743	0.00241	CcSEcCtD
Methylprednisolone—Vomiting—Esomeprazole—Barrett's esophagus	0.000743	0.00241	CcSEcCtD
Methylprednisolone—Rash—Esomeprazole—Barrett's esophagus	0.000737	0.00239	CcSEcCtD
Methylprednisolone—Rash—Omeprazole—Barrett's esophagus	0.000737	0.00239	CcSEcCtD
Methylprednisolone—Dermatitis—Omeprazole—Barrett's esophagus	0.000737	0.00239	CcSEcCtD
Methylprednisolone—Dermatitis—Esomeprazole—Barrett's esophagus	0.000737	0.00239	CcSEcCtD
Methylprednisolone—Headache—Omeprazole—Barrett's esophagus	0.000732	0.00238	CcSEcCtD
Methylprednisolone—Headache—Esomeprazole—Barrett's esophagus	0.000732	0.00238	CcSEcCtD
Methylprednisolone—Nausea—Omeprazole—Barrett's esophagus	0.000694	0.00226	CcSEcCtD
Methylprednisolone—Nausea—Esomeprazole—Barrett's esophagus	0.000694	0.00226	CcSEcCtD
Methylprednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—Barrett's esophagus	0.000615	0.0434	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000573	0.0404	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000573	0.0404	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—PPARG—Barrett's esophagus	0.000497	0.0351	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—MCL1—Barrett's esophagus	0.000368	0.026	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CYP26A1—Barrett's esophagus	0.000365	0.0257	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—Barrett's esophagus	0.000353	0.0249	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—Barrett's esophagus	0.000353	0.0249	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptors—PPARG—Barrett's esophagus	0.000321	0.0227	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—BMP4—Barrett's esophagus	0.000276	0.0195	CbGpPWpGaD
Methylprednisolone—NR3C1—Nuclear Receptor transcription pathway—PPARG—Barrett's esophagus	0.000254	0.0179	CbGpPWpGaD
Methylprednisolone—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000245	0.0173	CbGpPWpGaD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000224	0.0158	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000221	0.0156	CbGpPWpGaD
Methylprednisolone—NR3C1—Endoderm Differentiation—APC—Barrett's esophagus	0.000209	0.0147	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—SST—Barrett's esophagus	0.000203	0.0143	CbGpPWpGaD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000189	0.0133	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000182	0.0128	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—Barrett's esophagus	0.000166	0.0117	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CXCL8—Barrett's esophagus	0.00015	0.0106	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—RELA—Barrett's esophagus	0.00014	0.00991	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—NR1I2—Barrett's esophagus	0.000133	0.0094	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—Barrett's esophagus	0.000132	0.00934	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—Barrett's esophagus	0.00012	0.00847	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	0.000116	0.0082	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	9.65e-05	0.00681	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.52e-05	0.00672	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—Barrett's esophagus	9.22e-05	0.00651	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—Barrett's esophagus	8.12e-05	0.00573	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—Barrett's esophagus	7.91e-05	0.00558	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	7.33e-05	0.00517	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	6.73e-05	0.00475	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—NR1I2—Barrett's esophagus	6.41e-05	0.00452	CbGpPWpGaD
Methylprednisolone—Triamcinolone—PTGS2—Barrett's esophagus	5.96e-05	0.436	CrCbGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.91e-05	0.00346	CbGpPWpGaD
Methylprednisolone—Betamethasone—PTGS2—Barrett's esophagus	4.88e-05	0.357	CrCbGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—Barrett's esophagus	4.38e-05	0.00309	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.12e-05	0.00291	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.73e-05	0.00263	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGES—Barrett's esophagus	3.53e-05	0.00249	CbGpPWpGaD
Methylprednisolone—Dexamethasone—PTGS2—Barrett's esophagus	2.84e-05	0.208	CrCbGaD
Methylprednisolone—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	2.68e-05	0.00189	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.22e-05	0.00157	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.18e-05	0.00154	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—Barrett's esophagus	2.11e-05	0.00149	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	1.93e-05	0.00136	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.65e-05	0.00116	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.19e-05	0.000839	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—Barrett's esophagus	8.81e-06	0.000622	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—Barrett's esophagus	6.93e-06	0.000489	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—Barrett's esophagus	5.43e-06	0.000383	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.27e-06	0.000301	CbGpPWpGaD
